Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2017

Open Access 01-12-2017 | Case Report

Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review

Authors: Jingping Yuan, Liang He, Bing Han, Yan Li

Published in: World Journal of Surgical Oncology | Issue 1/2017

Login to get access

Abstract

Background

Primary peritoneal papillary serous carcinoma (PPPSC) is an uncommon disease which has a high malignancy and a poor prognosis.

Case presentation

We report here a long-term survival case of PPPSC with postoperative lung metastasis. A 62-year-old female patient with PPPSC was administered two cycles of neoadjuvant chemotherapy (NAC) followed by cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) and six cycles of platinum-based (docetaxel + carboplatin) intraperitoneal chemotherapy postoperatively. The patient reached a complete remission at the completion of primary treatment. Malignant thoracic effusion and lung metastasis developed 5 months after the treatment. The patient underwent video-assisted thoracoscopic surgery plus hyperthermic intrapleural chemotherapy.

Conclusions

Up to present, the patient has been survived with tumor for over 86 months with a good performance status, with only encapsulated effusion found at the latest follow-up. As a relatively new regime, the application of CRS + HIPEC in our patient has been proved example for MPE management, although more large-scale studies are needed to substantiate its efficiency and safety.
Literature
1.
go back to reference Bhuyan P, Mahapatra S, Sethy S, Parida P, Satpathy S. Extraovarian primary peritoneal papillary serous carcinoma. Arch Gynecol Obstet. 2010;281:561–4.CrossRefPubMed Bhuyan P, Mahapatra S, Sethy S, Parida P, Satpathy S. Extraovarian primary peritoneal papillary serous carcinoma. Arch Gynecol Obstet. 2010;281:561–4.CrossRefPubMed
2.
go back to reference Roffers SD, Wu XC, Johnson CH, Correa CN. Incidence of extraovarian primary cancers in the United States, 1992–1997. Cancer. 2003;97:2643–7.CrossRefPubMed Roffers SD, Wu XC, Johnson CH, Correa CN. Incidence of extraovarian primary cancers in the United States, 1992–1997. Cancer. 2003;97:2643–7.CrossRefPubMed
3.
go back to reference Bloss JD, Brady MF, Liao SY, Rocereto T, Partridge EE, Clarke-Pearson DL. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecol Oncol. 2003;89:148–54.CrossRefPubMed Bloss JD, Brady MF, Liao SY, Rocereto T, Partridge EE, Clarke-Pearson DL. Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma-a Gynecologic Oncology Group Study. Gynecol Oncol. 2003;89:148–54.CrossRefPubMed
4.
go back to reference Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Gynecol Oncol. 1996;60:393–6.CrossRefPubMed Ben-Baruch G, Sivan E, Moran O, Rizel S, Menczer J, Seidman DS. Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma. Gynecol Oncol. 1996;60:393–6.CrossRefPubMed
5.
go back to reference Eltabbakh GH, Werness BA, Piver S, Blumenson LE. Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol Oncol. 1998;71:230–9.CrossRefPubMed Eltabbakh GH, Werness BA, Piver S, Blumenson LE. Prognostic factors in extraovarian primary peritoneal carcinoma. Gynecol Oncol. 1998;71:230–9.CrossRefPubMed
6.
go back to reference Liu Q, Lin JX, Shi QL, Wu B, Ma HH, Sun GQ. Primary peritoneal serous papillary carcinoma: a clinical and pathological study. Pathol Oncol Res. 2011;17:713–9.CrossRefPubMed Liu Q, Lin JX, Shi QL, Wu B, Ma HH, Sun GQ. Primary peritoneal serous papillary carcinoma: a clinical and pathological study. Pathol Oncol Res. 2011;17:713–9.CrossRefPubMed
7.
go back to reference Sakakibara Y, Endo S, Yoshida Y, Tanaka Y, Hashimoto T, Ohara T. A case of serous surface papillary carcinoma of the peritoneum metastatic to the brain. No Shinkei Geka. 2011;39:607–10.PubMed Sakakibara Y, Endo S, Yoshida Y, Tanaka Y, Hashimoto T, Ohara T. A case of serous surface papillary carcinoma of the peritoneum metastatic to the brain. No Shinkei Geka. 2011;39:607–10.PubMed
8.
go back to reference Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004;28:1646–51.CrossRefPubMed Recine MA, Deavers MT, Middleton LP, Silva EG, Malpica A. Serous carcinoma of the ovary and peritoneum with metastases to the breast and axillary lymph nodes: a potential pitfall. Am J Surg Pathol. 2004;28:1646–51.CrossRefPubMed
9.
go back to reference Nakao M, Oguri T, Maeno K, Ota C, Takakuwa O, Iwashima Y, Miyazaki M, Kutsuna T, Nakamura A, Sato S, Ueda R. Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum. Intern Med. 2009;48:1165–8.CrossRefPubMed Nakao M, Oguri T, Maeno K, Ota C, Takakuwa O, Iwashima Y, Miyazaki M, Kutsuna T, Nakamura A, Sato S, Ueda R. Endobronchial metastasis from primary papillary serous carcinoma of the peritoneum. Intern Med. 2009;48:1165–8.CrossRefPubMed
10.
go back to reference Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575–81.CrossRefPubMedPubMedCentral Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575–81.CrossRefPubMedPubMedCentral
11.
go back to reference Iavazzo C, Vorgias G, Katsoulis M, Kalinoglou N, Dertimas V, Akrivos T. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Arch Gynecol Obstet. 2008;278:53–6.CrossRefPubMed Iavazzo C, Vorgias G, Katsoulis M, Kalinoglou N, Dertimas V, Akrivos T. Primary peritoneal serous papillary carcinoma: clinical and laboratory characteristics. Arch Gynecol Obstet. 2008;278:53–6.CrossRefPubMed
12.
go back to reference Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28:583–607.CrossRefPubMed Levy AD, Arnaiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28:583–607.CrossRefPubMed
13.
go back to reference Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, Mcmeekin S, Bloss LP, Disaia PJ. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347–51.CrossRefPubMed Bloss JD, Liao SY, Buller RE, Manetta A, Berman ML, Mcmeekin S, Bloss LP, Disaia PJ. Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347–51.CrossRefPubMed
14.
go back to reference Ordonez NG. Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Mod Pathol. 2013;26:553–62.CrossRefPubMed Ordonez NG. Value of PAX8, PAX2, claudin-4, and h-caldesmon immunostaining in distinguishing peritoneal epithelioid mesotheliomas from serous carcinomas. Mod Pathol. 2013;26:553–62.CrossRefPubMed
15.
go back to reference Pentheroudakis G, Pavlidis N. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol. 2010;75:27–42.CrossRefPubMed Pentheroudakis G, Pavlidis N. Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol. 2010;75:27–42.CrossRefPubMed
17.
go back to reference Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DM. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol. 2011;121:482–6.CrossRefPubMed Schmeler KM, Sun CC, Malpica A, Deavers MT, Bodurka DC, Gershenson DM. Low-grade serous primary peritoneal carcinoma. Gynecol Oncol. 2011;121:482–6.CrossRefPubMed
18.
go back to reference Vasudev NS, Trigonis I, Cairns DA, Hall GD, Jackson DP, Broadhead T, Buxton J, Hutson R, Nugent D, Perren TJ. The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma. Arch Gynecol Obstet. 2011;284:221–7.CrossRefPubMed Vasudev NS, Trigonis I, Cairns DA, Hall GD, Jackson DP, Broadhead T, Buxton J, Hutson R, Nugent D, Perren TJ. The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma. Arch Gynecol Obstet. 2011;284:221–7.CrossRefPubMed
19.
go back to reference Isik AF, Sanli M, Yilmaz M, Meteroglu F, Dikensoy O, Sevinc A, Camci C, Tuncozgur B, Elbeyli L. Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies. Respir Med. 2013;107:762–7.CrossRefPubMed Isik AF, Sanli M, Yilmaz M, Meteroglu F, Dikensoy O, Sevinc A, Camci C, Tuncozgur B, Elbeyli L. Intrapleural hyperthermic perfusion chemotherapy in subjects with metastatic pleural malignancies. Respir Med. 2013;107:762–7.CrossRefPubMed
20.
go back to reference Roh SY, Hong SH, Ko YH, Kim TH, Lee MA, Shim BY, Byun JH, Woo IS, Kang JH, Hong YS, Lee KS. Clinical characteristics of primary peritoneal carcinoma. Cancer Res Treat. 2007;39:65–8.CrossRefPubMedPubMedCentral Roh SY, Hong SH, Ko YH, Kim TH, Lee MA, Shim BY, Byun JH, Woo IS, Kang JH, Hong YS, Lee KS. Clinical characteristics of primary peritoneal carcinoma. Cancer Res Treat. 2007;39:65–8.CrossRefPubMedPubMedCentral
21.
go back to reference Morita H, Aoki J, Taketomi A, Sato N, Endo K. Serous surface papillary carcinoma of the peritoneum: clinical, radiologic, and pathologic findings in 11 patients. AJR Am J Roentgenol. 2004;183:923–8.CrossRefPubMed Morita H, Aoki J, Taketomi A, Sato N, Endo K. Serous surface papillary carcinoma of the peritoneum: clinical, radiologic, and pathologic findings in 11 patients. AJR Am J Roentgenol. 2004;183:923–8.CrossRefPubMed
22.
go back to reference Eisenhauer EL, Sonoda Y, Levine DA, Abu-Rustum NR, Gemignani ML, Sabbatini PJ, Barakat RR, Chi DS. Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. Am J Obstet Gynecol. 2008;198(213):e1–7. Eisenhauer EL, Sonoda Y, Levine DA, Abu-Rustum NR, Gemignani ML, Sabbatini PJ, Barakat RR, Chi DS. Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma. Am J Obstet Gynecol. 2008;198(213):e1–7.
Metadata
Title
Long-term survival of high-grade primary peritoneal papillary serous adenocarcinoma: a case report and literature review
Authors
Jingping Yuan
Liang He
Bing Han
Yan Li
Publication date
01-12-2017
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2017
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-017-1134-3

Other articles of this Issue 1/2017

World Journal of Surgical Oncology 1/2017 Go to the issue